We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKLI
1326
DELISTED
Akili Inc
AKLI
$5.14M 0.01%
519,631
+469,631
+939% +$4.63M
NXST icon
1327
Nexstar Media Group
NXST
$5.92B
$5.14M 0.01%
+27,250
New +$4.74M
GMBTW
1328
CALL
DELISTED
Pivotal Holdings Corp Warrant
GMBTW
$5.13M 0.01%
546,624
HD icon
1329
PUT
Home Depot
HD
$344B
$5.12M 0.01%
17,100
-27,000
-61% -$9.37M
PAC icon
1330
Grupo Aeroportuario del Pacifico
PAC
$12.9B
$5.11M 0.01%
31,696
+1,556
+5% +$219K
KOD icon
1331
Kodiak Sciences
KOD
$2.5B
$5.11M 0.01%
+661,537
New +$25.8M
TIGO icon
1332
Millicom
TIGO
$16B
$5.1M 0.01%
202,156
+155,326
+332% +$4.01M
CFFN icon
1333
Capitol Federal Financial
CFFN
$1.09B
$5.1M 0.01%
+468,394
New +$5.23M
KDP icon
1334
Keurig Dr Pepper
KDP
$42.2B
$5.09M 0.01%
134,340
-288,315
-68% -$10.9M
DNA icon
1335
Ginkgo Bioworks
DNA
$502M
$5.09M 0.01%
31,568
+28,862
+1,067% +$5.62M
DCT
1336
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
$5.08M 0.01%
229,734
+8,235
+4% +$197K
MSAI icon
1337
MultiSensor AI
MSAI
$9.69M
$5.07M 0.01%
12,767
LICY
1338
DELISTED
Li-Cycle Holdings Corp.
LICY
$5.06M 0.01%
74,853
-3,905
-5% -$249K
FRON
1339
DELISTED
Frontier Acquisition Corp. Class A Ordinary Shares
FRON
$5.06M 0.01%
516,566
BRLSW icon
1340
CALL
Borealis Foods Inc Warrant
BRLSW
$958K
$5.05M 0.01%
505,800
+70,678
+16% +$23.8K
NHI icon
1341
National Health Investors
NHI
$3.81B
$5.05M 0.01%
+85,630
New +$4.87M
GSD
1342
DELISTED
Global Systems Dynamics Inc. Class A Common Stock
GSD
$5.01M 0.01%
499,327
COUP
1343
DELISTED
Coupa Software Incorporated
COUP
$5.01M 0.01%
49,270
+45,416
+1,178% +$5.5M
MACC.WS
1344
CALL
DELISTED
Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
MACC.WS
$5M 0.01%
511,231
ITOS
1345
DELISTED
iTeos Therapeutics
ITOS
$5M 0.01%
155,373
-61,449
-28% -$2.23M
NETC.WS
1346
CALL
DELISTED
Nabors Energy Transition Corp. Warrants, exercisable for one share of Class A Common Stock
NETC.WS
$5M 0.01%
+499,999
New +$218K
LDHA
1347
DELISTED
LDH Growth Corp I Class A Ordinary Shares
LDHA
$5M 0.01%
510,761
+299,990
+142% +$2.92M
CORS
1348
DELISTED
Corsair Partnering Corporation
CORS
$4.99M 0.01%
514,189
TETCW
1349
CALL
DELISTED
Tech and Energy Transition Corporation Warrant
TETCW
$4.99M 0.01%
510,919
CMCA
1350
DELISTED
Capitalworks Emerging Markets Acquisition Corp Class A Ordinary Shares
CMCA
$4.97M 0.01%
+499,998
New +$4.96M

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.